venture capital
131 stories filed under venture capital on Beyond Market Intelligence. The newest of them: “Bluecore Energy secures $10M to explore portable nuclear power on barges”, “Colossal Biosciences eyes new funding to double its de-extinction valuation.”, and “Infinity raises $15M to build smarter infrastructure for AI-native data”. Bluecore Energy has raised $10 million in a pre-seed round led by Slauson & Co., a decisive step toward putting portable nuclear reactors on barges. Colossal Biosciences is reportedly in talks to raise new capital at a valuation between $20 billion and $30 billion, a move that would double or triple its previous worth. Acme AI is the next-generation, AI-powered spreadsheet platform built to replace Excel and redefine how analysts, data scientists, and enterprise teams work… The list below is every venture capital story on Beyond Market Intelligence, newest first.
Bluecore Energy secures $10M to explore portable nuclear power on barges
Bluecore Energy has raised $10 million in a pre-seed round led by Slauson & Co., a decisive step toward putting portable nuclear reactors on barges. That's not just ambitious; it's a practical answer to the grid's need for flexible, zero-carbon power. Maritime deployment could sidestep the land-use and siting battles that stall traditional builds, and that's worth watching closely. If you're tracking how capital is moving into dense, AI-driven infrastructure, our piece on Nscale's $3.36B raise offers a useful parallel.
Colossal Biosciences eyes new funding to double its de-extinction valuation.
Colossal Biosciences is reportedly in talks to raise new capital at a valuation between $20 billion and $30 billion, a move that would double or triple its previous worth. That kind of ambition signals confidence in a mission that goes far beyond the lab. It's a bold bet on the future of genetic restoration, and one worth watching closely. For more on how AI-native infrastructure is reshaping similar ventures, check out our piece on Nscale's recent funding.
Infinity raises $15M to build smarter infrastructure for AI-native data
Infinity's $15 million raise, backed by Touring Capital and researchers from OpenAI and Anthropic, signals something worth paying attention to. At a $100 million valuation, this isn't just another funding round; it's a bet that AI infrastructure can move beyond the hype and into practical, everyday use. We've seen how easily AI tools can mislead, as our own piece on catching AI slop before it skews your model shows. Infinity's work feels like a grounded step toward making that complexity manageable.
Complex funding rounds obscure the true cost of nuclear innovation.
Valar Atomics is in talks to raise new funding at a $6 billion valuation, a signal that investors are placing serious bets on the future of nuclear energy. The potential deal also highlights a growing trend toward complex, multi-stage funding rounds that obscure the true entry price for latecomers. It's a reminder that in capital-intensive sectors, the headline number rarely tells the whole story. For more on how AI-native companies are reshaping investment patterns, our piece on the $5.75B surge is worth a look.
Eight startups, one global stage: your final chance to compete
The deadline is real, and it's moving fast. Australian founders have 48 hours to secure their shot at Stripe Tour Sydney on August 19, where eight startups will pitch to investors and global press. The prize? Automatic entry into TechCrunch Disrupt in San Francisco, no strings attached. That's a rare, direct path to a world stage, and it's worth acting on now. If you're weighing the leap, remember the drive behind events like this mirrors the momentum we saw with Disrupt 2026's final-hour savings.
Tell your story with conviction to unlock pre-seed funding in a crowded market
Raising pre-seed funding in 2026 feels like a different beast. With AI startups absorbing record capital, investors are holding early founders to standards once reserved for later rounds. That pressure is real, but it's not insurmountable. At Disrupt 2026, we're cutting through the noise to show you how conviction and storytelling can carry a pitch, even without a polished product. This session is about turning your narrative into leverage.
Founders Fund adds a partner known for sharp analysis, not hype.
Founders Fund just added Ryan Beiermeister as a partner, and her appeal has nothing to do with being part of any so-called "Mafia." Her sharp, composed analysis on the firm's own YouTube series, "Mafia," showed a mind built for spotting what matters in complex systems. That kind of clarity is exactly what smart investing demands. It is a deliberate hire, one that signals a focus on substance over spectacle.
Aina pilots a new device designed to control AI agents, not just observe
Ultrahuman's former hardware VP has raised $5.5 million to build devices that don't just record your world, they act on it. The new company, Aina, plans to pilot its first device in the coming weeks, and that speed matters. This is about moving from passive capture to active control, a shift that feels overdue. For context on how AI agents already handle sensitive data, our piece on shared user images is worth a look. The potential here is real, but execution will define it.
Greylock's new fund prioritizes founder focus over fund size
Greylock capped its new fund at $1.5 billion, even as it admits more capital was on the table. That restraint is the point. By holding the number of investments to roughly 25 per fund, the firm is choosing depth over breadth, aiming to be what it calls "the most important partner" to its founders. It's a deliberate bet on focus, and one that feels increasingly rare. For context on how AI-native infrastructure is drawing similar conviction elsewhere, Nscale's $3.36B raise shows the appetite for scale.
Neko Health raises $700 million to expand proactive body scanning
Daniel Ek's Neko Health just closed another $700M round, and that tells you something important: proactive health is moving from niche to necessary. The startup pairs proprietary full-body scanning with bloodwork to give people a clearer read on where they stand. That's the kind of clarity traditional checkups rarely deliver. We're watching capital flow into tools that put users in control, much like the discussions coming at Disrupt 2026. If you're tracking where wellness and entrepreneurship converge, this is a space worth exploring.
Indian AI coding startup hits unicorn status with 200,000 paying users
Emergent just crossed into unicorn territory, and the timing feels right. The Indian AI coding startup closed a $130M Series C, hitting a $120 million annualized revenue run rate with over 200,000 paying customers. That is real traction, not hype. It signals a growing comfort with AI-native development tools, especially as teams look to simplify complex workflows.